1. Home
  2. LMNR vs TLSI Comparison

LMNR vs TLSI Comparison

Compare LMNR & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limoneira Co

LMNR

Limoneira Co

HOLD

Current Price

$14.00

Market Cap

264.6M

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$7.07

Market Cap

244.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMNR
TLSI
Founded
1893
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
264.6M
244.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LMNR
TLSI
Price
$14.00
$7.07
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$20.50
$10.67
AVG Volume (30 Days)
86.9K
155.3K
Earning Date
12-22-2025
11-13-2025
Dividend Yield
2.14%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$160,763,000.00
$40,207,000.00
Revenue This Year
N/A
$55.06
Revenue Next Year
N/A
$46.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
49.52
52 Week Low
$12.69
$3.42
52 Week High
$28.17
$7.32

Technical Indicators

Market Signals
Indicator
LMNR
TLSI
Relative Strength Index (RSI) 52.72 74.64
Support Level $13.57 $6.06
Resistance Level $14.31 $7.32
Average True Range (ATR) 0.36 0.55
MACD 0.13 0.18
Stochastic Oscillator 77.73 91.91

Price Performance

Historical Comparison
LMNR
TLSI

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Share on Social Networks: